C. S. Nelson

发表

Listeriolysin O is a target of the immune response to Listeria monocytogenes

H. Bouwer, D. Portnoy, C. S. Nelson, 1992, The Journal of experimental medicine.

Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk

T. Kepler, M. Hudgens, H. Liao, 2016, Journal of Virology.

Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants.

L. Kauvar, D. Westreich, T. Fu, 2016, The Journal of infectious diseases.

Pediatric HIV-1 Acquisition and Lifelong Consequences of Infant Infection.

G. Fouda, C. S. Nelson, S. Permar, 2019, Current immunology reviews.

Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys

K. Koelle, M. Cohen-Wolkowiez, P. Barry, 2017, bioRxiv.

Multivalent Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccines Demonstrate a Greater Breadth in T cell but not Antibody Responses

D. Weissman, Cliburn Chan, Leike Li, 2022, bioRxiv.

Defining the Role of Antibodies in Protection Against Cytomegalovirus Acquisition and Congenital Disease for Rational Vaccine Design

C. S. Nelson, 2018 .

Maternal immune correlates of protection against placental transmission of cytomegalovirus.

C. S. Nelson, S. Permar, D. Martinez, 2017, Placenta.

High-resolution micro-epidemiology of parasite spatial and temporal dynamics in a high malaria transmission setting in Kenya

Kelsey M. Sumner, C. S. Nelson, W. O'Meara, 2019, Nature Communications.

Cutaneous host defense in leishmaniasis: interaction of isolated dermal macrophages and epidermal Langerhans cells with the insect-stage promastigote

R. Locksley, C. S. Nelson, J. Fankhauser, 1988, Infection and immunity.

Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees

K. Koelle, M. Diener-West, C. S. Nelson, 2018, Journal of Virology.

Genetic signatures of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees

K. Koelle, M. Diener-West, C. S. Nelson, 2018, bioRxiv.

Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.

P. Griffiths, I. Baraniak, M. Reeves, 2020, The Journal of infectious diseases.

HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions

C. S. Nelson, N. Vandergrift, J. Pollara, 2018, Proceedings of the National Academy of Sciences.

Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans

D. Bernstein, K. Edwards, E. Walter, 2020, Science Translational Medicine.

Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization

D. Weissman, J. McLellan, C. S. Nelson, 2020, Journal of Virology.

Intrahost cytomegalovirus population genetics following antibody pretreatment in a monkey model of congenital transmission

K. Koelle, P. Barry, C. S. Nelson, 2020, PLoS pathogens.

HCMV glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization

D. Weissman, J. McLellan, C. S. Nelson, 2019 .

Relationship of maternal cytomegalovirus-specific antibody responses and viral load to vertical transmission risk following primary maternal infection in a rhesus macaque model

K. Früh, Cliburn Chan, P. Barry, 2023, bioRxiv.

Impact of preexisting virus-specific maternal antibodies on cytomegalovirus population genetics in a monkey model of congenital transmission

K. Koelle, P. Barry, C. S. Nelson, 2019, bioRxiv.

Loss of granule myeloperoxidase during in vitro culture of human monocytes correlates with decay in antiprotozoa activity.

R. Locksley, C. S. Nelson, S. Klebanoff, 1987, The American journal of tropical medicine and hygiene.

HCMV glycoprotein B subunit vaccine efficacy was mediated by non-neutralizing antibody effector functions

C. S. Nelson, N. Vandergrift, J. Pollara, 2018, bioRxiv.

Antibody binding to native cytomegalovirus glycoprotein B predicts vaccine efficacy

D. Bernstein, K. Edwards, E. Walter, 2020 .

Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection

J. McLellan, D. Wrapp, T. Fu, 2020, bioRxiv.

2651. Protection Against Human Cytomegalovirus Acquisition Is Associated with IgG Binding to Cell-Associated CMV glycoprotein B in Two Historical gB/MF59 Vaccine Cohorts

D. Bernstein, Cliburn Chan, C. S. Nelson, 2019, Open Forum Infectious Diseases.

Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys

K. Koelle, Meng Chen, M. Cohen-Wolkowiez, 2017, bioRxiv.

A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection

B. Herold, C. S. Nelson, S. Permar, 2018, npj Vaccines.

Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission

T. Gurley, M. A. Moody, Joshua D. Amos, 2017, Clinical and Vaccine Immunology.

A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection

B. Herold, C. S. Nelson, S. Permar, 2018, npj Vaccines.

Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys

K. Koelle, Meng Chen, M. Cohen-Wolkowiez, 2017, bioRxiv.

Preexisting antibodies can protect against congenital cytomegalovirus infection in 3 monkeys 4 5

K. Koelle, Meng Chen, M. Cohen-Wolkowiez, 2017 .

Leishmaniasis: Interaction of Isolated Dermal Macrophages and Epidermal Langerhans Cells with the Insect-Stage Promastigote

R. Locksley, C. S. Nelson, J. Fankhauser, 2022 .